Roche Offer for Illumina Fair, Compelling: CEO
February 03, 2012 at 12:44 PM EST
Roche is willing to spend $5.7 billion on what could be a hostile takeover of Illumina to get into the gene-sequencing market, CEO Severin Schwan told CNBC Friday.
